Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Pancreatic Neoplasms 8 Ovarian Neoplasms 5 Mesothelioma, Malignant 4 Carcinoma, Non-Small-Cell Lung 4 Lung Neoplasms 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Stomach Neoplasms 2 Neoplasms 2 Mesothelioma 2 Melanoma 2 Glioblastoma 2 Uveal Melanoma 1 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Phase IB 1 Non Hematologic Cancers 1 Neoplasms, Mesothelial 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mesonephric Gynecologic Cancer 1 Lymphoma 1 Low-Grade Serous Ovarian Cancer 1 Low Grade Serous Ovarian Cancer 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1

Interventions

Temozolomide 162 Radiosurgery 115 Radiotherapy 100 Bevacizumab 96 Magnetic Resonance Spectroscopy 65 Carboplatin 48 Etoposide 34 pembrolizumab 33 Surgical Procedures, Operative 33 Irinotecan 33 Nivolumab 32 Cyclophosphamide 32 Erlotinib Hydrochloride 31 Radiation 30 Carmustine 28 Lomustine 25 Cisplatin 25 Trastuzumab 23 Ipilimumab 23 Filgrastim 23 Vincristine 20 Mental Status and Dementia Tests 20 Aminolevulinic Acid 19 Topotecan 18 Pemetrexed 18 Capecitabine 18 Specimen Handling 17 Sorafenib 15 Radiotherapy, Intensity-Modulated 15 Imatinib Mesylate 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Brain Neoplasms × defactinib × Clear all

NCT06194929 2025-12-03

DETERMINE

University of Utah

Phase 1/2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡